DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Methicillin-Resistant Staphylococcus aureus (MRSA) - Current and Future Players" report to their offering.
Methicillin-Resistant Staphylococcus aureus (MRSA) - Current and Future Players. The report is a vital source of up-to-date information with in-depth analysis on the companies in the rapidly growing MRSA Market. The report identifies and analyses the key companies shaping and driving the global MRSA market. The report provides insight into the competitive MRSA landscape, including new companies entering the market. This report is built using data and information sourced from proprietary databases, primary and secondary and in-house analysis by our team of industry experts.
Scope
- Investigation of current and future market competition for MRSA
- Competitor assessment
- Coverage of key market players and company profiles including business description, financial overview and SWOT analysis.
- Strategic assessment of MRSA sector through market impact analysis, future market scenario and company analysis
Key Topics Covered:
1 Tables & Figures
2 Introduction
3 Market Outlook
3.1 Global Markets
3.1.1 Forecast
3.1.2 Drivers and Barriers - Global Issues
4 Current and Future Players
4.1 Overview
4.2 Trends in Corporate Strategy
4.3 Company Profiles - Current Players
4.3.1 Pfizer
4.3.2 Merck
4.3.3 Allergan
4.3.4 The Medicines Company
4.3.5 Theravance Biopharma
4.3.6 Basilea Pharmaceutica
4.3.7 Sanofi
4.4 Additional Companies with Promising Pipeline Products
4.4.1 Melinta Therapeutics
4.4.2 Cempra Pharmaceuticals
4.4.3 Paratek Pharmaceuticals
4.4.4 Kyorin Pharmaceutical
4.4.5 Nabriva Therapeutics
4.4.6 Debiopharm International
4.4.7 Cellceutix Corporation
5 Appendix
For more information visit http://www.researchandmarkets.com/research/4kn2dv/methicillinresist
